Kovid-19 vaccine data leaked after cyber attackers EU hack

Photographer: Oliver Brick / Bloomberg

Hackers posted confidential documents about Kovid-19 drugs and vaccines on the Internet Data breech at the end of last year European Medicines Agency.

The EMA stated that the time related to the evaluation and approval of Kovid drugs and vaccines has not been affected. Statement on Tuesday. The agency said it is fully functional and law enforcement officials are taking action on the violation.

Some of the documents caught in the hack were presented by Pfizer Inc. and BioNTech SE during a regulatory review of their vaccine, approved last month. The EMA stated that it would notify any additional entities and individuals whose documents and personal data may be subject to unauthorized access.

Pfizer’s shares fell 2.2% in New York, with BioNtech’s US depository down 5.1%.

The EMA’s update on breech came after Yarix, an Italian cybercity firm, said it had hacked documents related to the authorization and commercial processes of the Pfizer-BioNTech vaccine on the so-called Dark Web.

An attacker released a blog post containing EMA’s files containing confidential email messages related to vaccine production and marketing, Yerix’s chief executive officer Mirko Gatto said in an interview. Gatto said the screen shots and documents in the post referred to the EMA Secure Communications Portal which is reserved for authorized personnel.

Italian authorities

Yarix reported the case to Italian authorities, the CEO said, but it is not working directly with the EMA. The agency did not immediately respond to a request for comment on the firm’s disclosures.

Pfizer and BioNotech said last month that some documents handed over to the EMA were accessed in the hack. The companies said that none of their systems were broken.

A Pfizer spokesperson declined to comment beyond the initial statement in December. A BioNTech representative did not immediately respond to requests for comment.

EMA signed a second vaccine from Modern Inc. earlier this month. There is a third vaccine currently under review, which has been developed AstraZeneca plc and Oxford University. The regulator has said its drugs advisory panel can issue an opinion on that shot by January 29.

EMA is also rolling review of potential vaccines Johnson & Johnson, though a decision on that shot, is further closed because a large late stage trial has not yet produced results.

Since the epidemic began, hackers aligned with governments including Russia and China have been accused of targeting companies and research institutes.

Cyber ​​Security Researcher International Business Machines Corp revealed that unknown hackers were targeting companies and government agencies involved in vaccine distribution. Microsoft Corp said hackers in Russia and North Korea had targeted seven “major” companies working on vaccines and treatment research.

(Updates with comments from Italian security firm in fifth through seventh paragraph)


Leave a Reply

Your email address will not be published.